Skip to main content
×
×
Home

Epidemiology and clinical outcomes of patients with Fusobacterium bacteraemia

  • E. A. GOLDBERG (a1), T. VENKAT-RAMANI (a2), M. HEWIT (a1) and H. F. BONILLA (a3)
Summary

This 10-year retrospective study assessed the epidemiology and outcomes of patients with Fusobacterium bacteraemia (FB) at a tertiary-care hospital in the USA – this is the second study focusing on FB in adults to be conducted in the USA in 30 years. Demographic, clinical, laboratory, treatment, and outcome data were collected and statistically analysed. Nineteen patients with FB were identified, representing 0·11% of bacteraemia cases. Mean age was 58·6 years with equal gender distribution. Common comorbidities included cardiovascular disease (CVD) and immunosuppression. Thirty-day mortality was 21·1%, and 68·4% of FB patients required intensive care unit (ICU) admission. Elevated creatinine levels and mental status changes were associated with higher mortality (P = 0·0181 and 0·0374, respectively). CVD, diabetes, and ICU admission were associated with increased length of hospital stay (P = 0·0017, 0·0010, and 0·0379, respectively). The prevalence of FB at our hospital was very low, with poor outcomes associated with increased creatinine level, mental status changes, CVD, diabetes and ICU admission.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Epidemiology and clinical outcomes of patients with Fusobacterium bacteraemia
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Epidemiology and clinical outcomes of patients with Fusobacterium bacteraemia
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Epidemiology and clinical outcomes of patients with Fusobacterium bacteraemia
      Available formats
      ×
Copyright
Corresponding author
*Author for correspondence: H. F. Bonilla, M.D., Clinical Assistant Professor of Medicine, UPMC Mercy, Division of Infectious Diseases, 1400 Locust Street, Ermire Building B, Room 10547, Pittsburgh, PA 15219, USA. (Email: Bonillah@UPMC.edu)
References
Hide All
1.Su, CP, et al. Fusobacterium bacteremia: clinical significance and outcomes. Journal of Microbiology, Immunology and Infection 2009; 42: 336342.
2.Fanourgiakis, P, et al. Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases. Supportive Care in Cancer 2003; 11: 332335.
3.Huggan, PJ, Murdoch, DR. Fusobacterial infections: clinical spectrum and incidence of invasive disease. Journal of Infection 2008; 57: 283289.
4.Epaulard, O, et al. The changing pattern of Fusobacterium infections in humans: recent experience with Fusobacterium bacteraemia. Clinical Microbiology and Infection 2006; 12: 178181.
5.Yang, CC, et al. Characteristics and outcomes of Fusobacterium nucleatum bacteremia – a 6-year experience at a tertiary care hospital in northern Taiwan. Diagnostic Microbiology and Infectious Disease 2011; 70: 167174.
6.Karkos, PD, et al. Lemierre's syndrome: a systematic review. The Laryngoscope 2009; 119: 15521559.
7.Hagelskjaer Kristensen, L, Prag, J. Lemierre's syndrome and other disseminated Fusobacterium necrophorum infections in Denmark: a prospective epidemiological and clinical survey. European Journal of Clinical Microbiology & Infectious Diseases 2008; 27: 779789.
8.Henry, S, DeMaria, A Jr., McCabe, WR. Bacteremia due to Fusobacterium species. American Journal of Medicine 1983; 75: 225231.
9.Bourgault, AM, et al. Fusobacterium bacteremia: clinical experience with 40 cases. Clinical Infectious Diseases 1997; 25 (Suppl. 2): S181183.
10.Nohrstrom, E, et al. Clinical spectrum of bacteraemic Fusobacterium infections: from septic shock to nosocomial bacteraemia. Scandinavian Journal of Infectious Diseases 2011; 43: 463470.
11.Brook, I. Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. Journal of Infectious Diseases 1989; 160: 10711075.
12.Chaim, W, Mazor, M. Intraamniotic infection with fusobacteria. Archives of Gynecology and Obstetrics 1992; 251: 17.
13.Guarner, F, Malagelada, JR. Gut flora in health and disease. Lancet 2003; 361: 512519.
14.Marshall, JC. Gastrointestinal flora and its alterations in critical illness. Current Opinion in Clinical Nutrition & Metabolic Care 1999; 2: 405411.
15.Citron, DM, Poxton, IR, Baron, EJ. Bacteroides, porphyromonas, prevotella, fusobacterium, and other anaerobic gram-negative rods. In: Murray, PR, et al. , eds. Manual of Clinical Microbiology, 9th edn.Washington, D.C.: ASM Press, 2009, pp. 911932.
16.Liu, CY, et al. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrobial Agents and Chemotherapy 2008; 52: 31613168.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: -
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed